PubRank

Anthony A Bavry

Author PubWeight™ 52.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010 5.06
2 Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol 2013 2.99
3 Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol 2010 2.83
4 Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension. J Hypertens 2014 2.28
5 Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. J Am Coll Cardiol 2010 1.76
6 Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines. J Am Coll Cardiol 2011 1.62
7 Limitations of the MEDLINE database in constructing meta-analyses. Ann Intern Med 2010 1.48
8 Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension 2012 1.46
9 The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials. J Hypertens 2014 1.45
10 Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes 2014 1.41
11 Aspiration thrombectomy in patients undergoing primary angioplasty: totality of data to 2013. Catheter Cardiovasc Interv 2014 1.33
12 Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med 2010 1.17
13 An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). J Interv Cardiol 2010 1.14
14 Development of coronary aneurysm after drug-eluting stent implantation. Ann Intern Med 2007 1.14
15 Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up. Am J Med 2009 1.07
16 Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. Am Heart J 2011 1.04
17 Is clopidogrel cardiovascular medicine's double-edged sword? Circulation 2006 1.01
18 Silent ischemia: clinical relevance. J Am Coll Cardiol 2012 0.99
19 The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials. Am Heart J 2008 0.91
20 A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis. Am J Cardiol 2006 0.89
21 Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials. Am J Cardiovasc Drugs 2007 0.89
22 Fractional flow reserve: an updated review. Clin Cardiol 2014 0.87
23 The association between NSAID use and colorectal cancer mortality: results from the women's health initiative. Cancer Epidemiol Biomarkers Prev 2012 0.86
24 Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention. Am J Cardiol 2007 0.85
25 Presence of carotid and peripheral arterial disease in patients with left main disease. Am J Cardiol 2007 0.84
26 Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events. Cleve Clin J Med 2013 0.83
27 Mortality risk associated with bundle branch blocks and related repolarization abnormalities (from the Women's Health Initiative [WHI]). Am J Cardiol 2012 0.83
28 Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention. Am J Cardiol 2012 0.82
29 Does the Baseline Coronary Lesion Length Impact Outcomes With IVUS-Guided Percutaneous Coronary Intervention? J Am Coll Cardiol 2016 0.82
30 Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridines. Clin Cardiol 2011 0.81
31 Acute coronary syndrome (unstable angina and non-ST elevation MI). BMJ Clin Evid 2009 0.80
32 Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents. Am Heart J 2008 0.79
33 The optimal treatment of carotid atherosclerosis: a 2008 update and literature review. Postgrad Med 2008 0.79
34 Drug-eluting stents: dual antiplatelet therapy for every survivor? Circulation 2007 0.77
35 Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST--segment elevation myocardial infarction: a meta-analysis of 15 randomized trials. Catheter Cardiovasc Interv 2014 0.77
36 Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes. Am J Cardiol 2006 0.76
37 Non ST-elevation acute coronary syndrome. BMJ Clin Evid 2010 0.75
38 Routine vs selective invasive strategies in acute coronary syndromes. JAMA 2005 0.75
39 Acute myocardial infarction and drug-eluting stents: a green light for their use or time for measured restraint? Am Heart J 2007 0.75
40 Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy. PLoS One 2016 0.75
41 Designing the ideal risk model for acute coronary syndromes--is simple better than complex? Am Heart J 2007 0.75
42 Possible benefit to survival from early invasive strategies in patients with acute coronary syndromes. Ann Intern Med 2008 0.75
43 Reply: aspiration thrombectomy: an easily forgiven "latecomer". J Am Coll Cardiol 2014 0.75
44 Images in Cardiovascular Medicine. Don't turn your head! Circulation 2009 0.75
45 Treatment of hypertension: lower is better, or is it? Hypertension 2012 0.75
46 Paving the coronaries with stents: okay in acute coronary syndromes? Clin Cardiol 2011 0.75
47 Risk of Bleeding in End-Stage Liver Disease Patients Undergoing Cardiac Catheterization. Tex Heart Inst J 2015 0.75
48 Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent. Am J Cardiol 2006 0.75
49 Acute myocardial infarction. Am J Med 2005 0.75
50 Acute myocardial infarction during infusion of liposomal doxorubicin for recurrent breast cancer. Breast J 2010 0.75
51 Drug-eluting stents: can we move beyond stent thrombosis? Am Heart Hosp J 2007 0.75
52 Understanding and minimizing late thrombosis of drug-eluting stents. Cleve Clin J Med 2007 0.75
53 Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis? Indian Heart J 2009 0.75
54 Reply: Mechanical Thrombectomy for Ischemic Stroke. J Am Coll Cardiol 2016 0.75
55 Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness. Am Surg 2015 0.75
56 Reply: Meta-Analysis of Strategies for Patients With Multivessel Disease Undergoing Percutaneous Coronary Intervention: Does the Timing of Staged Procedures Matter? JACC Cardiovasc Interv 2017 0.75
57 The Risk for Stroke With Aspiration Thrombectomy: Procedure or Patient Related?: Insights From a Meta-Analysis. JACC Cardiovasc Interv 2016 0.75
58 The Hidden Players. JACC Cardiovasc Interv 2016 0.75
59 Drug-eluting stents versus bare-metal stents for saphenous vein graft revascularisation: A meta-analysis of randomised trials. EuroIntervention 2017 0.75
60 Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort. J Hypertens 2017 0.75
61 Bare metal stent thrombosis 13 years after implantation. Cardiovasc Revasc Med 2009 0.75
62 Clopidogrel and coronary stents: risks and benefits. Curr Atheroscler Rep 2008 0.75